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ORIGINAL ARTICLE

A cell autonomous role for the Notch ligand
Delta-like 3 in ab T-cell development
Gerard F Hoyne1,2, Gavin Chapman3,4, Yovina Sontani1,5, Sharon E Pursglove3 and Sally L Dunwoodie3,4
Notch signalling is critical to help direct T-cell lineage commitment in early T-cell progenitors and in the development of
ab T-cells. Epithelial and stromal cell populations in the thymus express the Notch DSL (Delta, Serrate and Lag2)ligands
Delta-like 1 (Dll1), Delta-like 4 (Dll4), Jagged 1 and Jagged 2, and induce Notch signalling in thymocytes that express the
Notch receptor. At present there is nothing known about the role of the Delta-like 3 (Dll3) ligand in the immune system.
Here we describe a novel cell autonomous role for Dll3 in ab T-cell development. We show that Dll3 cannot activate Notch when
expressed in trans but like other Notch ligands it can inhibit Notch signalling when expressed in cis with the receptor. The loss
of Dll3 leads to an increase in Hes5 expression in double positive thymocytes and their increased production of mature CD4+
and CD8+ T cells. Studies using competitive irradiation chimeras proved that Dll3 acts in a cell autonomous manner to regulate
positive selection but not negative selection of autoreactive T cells. Our results indicate that Dll3 has a unique function during
T-cell development that is distinct from the role played by the other DSL ligands of Notch and is in keeping with other recent
studies indicating that Dll1 and Dll3 ligands have non-overlapping roles during embryonic development.
Immunology and Cell Biology advance online publication, 14 December 2010; doi:10.1038/icb.2010.154
Keywords: Notch ligands; Notch; T cells; thymus
The DSL (Delta, Serrate and Lag2) family of Notch ligands are single
pass type I transmembrane proteins that contain an N-terminal cysteine
rich DSL domain, epidermal growth factor-like repeats, a transmembrane domain and a C-terminal domain of variable length.1 Notch
signalling is transmitted through interaction between Notch ligands on
one cell and Notch receptors expressed on a neighbouring cell. This
interaction elicits a series of specific proteolytic cleavage events that
culminate in the release of the intracellular domain of Notch (Notch
IC).2 Notch IC enters the nucleus where it interacts with the CBF1/
Su(H)/Lag1 (CSL) DNA-binding protein to activate downstream genes
such as those of the HES and HEY families of basic-loop-helix
transcription factors.2 In mammals, Notch signalling is mediated by
the Delta-like (Dll1, Dll4) and Serrate-like (Jagged1, Jagged2) DSL
ligands.3–6 In addition both classes of DSL ligands can inhibit Notch
signalling when expressed in the same cell as Notch; this phenomenon is
referred to as cis or cell autonomous inhibition of Notch signalling.7–9
The investigation of DSL Notch ligands in T-cell development has
largely focussed on their role in stromal cell populations and previous
studies have identified that the Delta-like and Serrate-like ligands are
critical to drive commitment to the T-cell lineage, but little is known
about the role of Notch signalling beyond the double positive (DP)
stage of thymocyte development following positive or negative selection.4–6,10,11 Originally it was thought that the Dll1 and Dll4 ligands
had redundant roles in the thymus as deletion of Dll1 in thymic

stroma did not block T-cell development and stromal cells ectopically
expressing either Dll1 or Dll4 were sufficient in supporting T-cell
development in vitro.4,11 However, more recent studies have shown
that Dll4 is the primary ligand expressed by thymic epithelial cells that
direct T-cell differentiation in haematopoietic progenitors.12,13 At
present there is nothing known about the role of the Delta-like
3 (Dll3) ligand in the thymus and whether or not it has a role in
regulating T-cell development. This is an important issue as Dll3 is
likely to function differently to the other DSL ligands in embryonic
development.8,14 Here we show that Dll3 is unique amongst DLS
ligands of Notch. It is expressed in thymocytes and is most abundant
on mature T cells. We have examined T-cell development in Dll3
deficient mice and find that in the absence of Dll3 there is increased
positive selection of DP thymocytes to both CD4+ and CD8+ T-cell
lineages whereas negative selection of autoreactive T cells remains
intact. The loss of Dll3 leads to an increase in T-cell receptor (TCR)
signalling in DP cells and an increase in Hes5 expression. Thus Dll3
acts in a cell autonomous manner to regulate Notch signalling and this
is important in regulating TCR signal strength.
RESULTS
Dll3 expression by thymocytes
We examined the expression of Notch1 and different DSL ligands
using RNA prepared from fluorescence-activated cell sorting (FACS)
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Figure 1 Dll3 expression in T-cell development. (a) Real time PCR expression of Notch1 (filled bars), Dll1 (hatched bars), Dll3 (open bars), Jagged1
(grey bars) and Jagged2 (stippled bars) in thymocytes at different stages of T-cell development. Data represent the average expression in three independent
cell isolations. ND¼not detected. (b) Western blot detection of Dll3 protein (using a novel anti-Dll3 antiserum) in lysates from C2C12 cells transfected with
Dll3-HA (D3) but not in lysates from Dll1HA transfected (D1) nor from untransfected cells (). Dll1 expression was demonstrated on the same blot using an
antibody against mouse Dll1. (c) Thymocytes were stained initially with anti-CD4, CD8, TCR-b and following intracellular permeabilisation were stained with
anti-Dll3. Thymocytes were gated on DN (CD4CD8), DP (CD4+CD8+), CD4 or CD8 SP cells and the staining shows the expression of Dll3 versus TCR-b in
the different cell populations for Dll3+/+ cells compared with Dll3/ mice, which serves as a negative control. The data are representative of one of four
experiments performed with a total of 12 mice. (d) Lineage negative thymocytes were stained with anti-CD44 and anti-CD25 to identify the different DN cell
subsets and FACS sorted and stained intracellularly with anti-Dll3. Data show representative histograms of Dll3 expression on DN1, DN2, DN3 and DN4
cells in the thymus of Dll3+/+ (grey line) and the Dll3/ (black line).

sorted double negative (DN), DP, CD4 single positive (SP) and CD8
SP thymocytes using real time PCR. The Dll3 gene is expressed at all
stages of T-cell development; expression was highest in DN cells,
lowest in DP thymocytes and the predominant ligand in CD4 and
CD8 SP cells (Figure 1a). Notably Dll1, Jagged1 and Jagged2 were
absent from DN and DP cells, but were detected in CD4 and CD8 SP
cells as previously published (Figure 1a).15 Notch1 expression showed
Dll3 being high in DN cells, low in DP cells and higher in SP cells
(Figure 1a).16 Next we examined the expression of the Dll3 protein in
thymocytes using a polyclonal antibody raised to a peptide sequence
on the C-terminus of the Dll3 protein that is highly divergent to other
DSL ligands.14 The specificity of the Dll3 antibody was determined by
Immunology and Cell Biology

western blotting to lysates from Dll3- or Dll1-transfected C2C12 cells.
As shown in Figure 1b the Dll3 antibody was specific for the Dll3
protein and does not cross react with the related Dll1 ligand
(or Jagged1 (data not shown)), nor did it bind non-specifically to
cell extracts. Next we examined the expression of the Dll3 ligand in
Dll3+/+ thymocytes that were stained intracellularly and analysed
by FACS, whereas Dll3/ thymocytes served as an effective negative
control. The Dll3 protein was readily detected in a subset of mature
CD4+ TCR-bhi (14%) and CD8+ TCR-bhi (10%) cells and was also
detected in TCR-blo DP and DN thymocytes cells (Figure 1c). Lineage
negative thymocytes were stained with CD44 and CD25 to identify the
different DN cell types and following FACS sorting were analysed for
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Figure 2 Loss of Dll3 leads to an expansion of mature T cells in the thymus
and spleen. Graphs display the percentage of (a) CD4+ and CD8+
thymocytes and (b) CD4+ and CD8+ splenocytes in Dll3+/+, Dll3+/ and
Dll3/ mice. Mice were aged and sex matched; Dll3+/+ (n¼8), Dll3+/
(n¼4) and Dll3/ (n¼12). Bars represent the average for each group.
Unpaired t-test was used to test for statistically significant differences
between groups. **Po0.01, ***Po0.001. (c) The absolute numbers of
CD4+ and CD8+ T cells in the thymus and spleen of chimaeric mice. The
origin of the donor cells in each chimaera was distinguished on the basis of
CD45 allelic expression by FACS and the number of CD45.2 and CD45.1
derived CD4+ and CD8+ T cells was calculated. Cells from the Dll3+/+/
CD45.1 chimeras (filled squares), and Dll3//CD45.1 chimaeras (open
triangles) are shown.

Dll3 expression by FACS. Dll3 was predominantly expressed by DN2
and DN3 cells and was lowest in DN1 and DN4 stage cells (Figure 1d).
These results indicate that Dll3 is expressed around the time of
b-selection, which occurs in DN3 stage thymocytes.
Dll3 acts cell autonomously to regulate T-cell production in vivo
The generation of Dll3/ mice has been described.17 On a pure
C57BL/6 background, Dll3/ mice die at birth but on a mixed (129/
C57BL/6) F2 background, Dll3/ mice are viable and are born at the
expected Mendelian frequencies. We examined T-cell development in
the thymus of Dll3+/+, Dll3+/ and Dll3/ F2 mice by flow cytometry
and each of the major T-cell subsets were present indicating that Dll3 is
not absolutely required for normal T-cell differentiation. However there
was a significant increase in the frequency of CD8+ T cells in Dll3/
thymus compared with Dll3+/+ and Dll3+/ mice (Po0.01) and a trend
towards increased CD4+ cell frequency that just failed to reach statistical
significance (Figure 2a). In the spleen there was a significant increase in
the frequency of both CD4+ and CD8+ T cells in Dll3/ mice
compared with Dll3+/+ and Dll3+/ mice (Po0.001) (Figure 2b).
The changes in CD4+ and CD8+ T-cell frequencies in the thymus
and spleen of Dll3/ mice prompted us to use mixed fetal liver cell
chimeras to assess the contribution of the stromal compartment to the

changes in the observed T-cell frequencies. To avoid complications
with the F2 mixed genetic background in the irradiation chimeras
we chose to use fetal liver cells from Dll3/ and Dll3+/+ mice on a
C57BL/6 background. The initial group of chimeras was generated by
injecting an equal mix (50:50) of CD45.1 and Dll3/ (CD45.2) fetal
liver cells into irradiated CD45.1 recipients or CD45.1 and Dll3+/+
(CD45.2) fetal liver cells into irradiated CD45.1 recipients. Thymus
and spleen cells of the recipient mice were examined 12 weeks after the
transfer. Cells were stained and analysed by flow cytometry and the
donor-derived cells were distinguished on the basis of differences in
CD45 allelic expression.
The Dll3/ progenitors were able to compete effectively with
wild-type CD45.1 cells leading to normal CD4+ and CD8+ T-cell
differentiation. It was noticeable that the Dll3/ progenitors gave rise
to 3–4 fold more mature CD4+ and CD8+ T cells in the thymus
compared with the Dll3+/+ CD45.2 progenitors (P¼0.01) and this
difference was also maintained in the spleen (P¼0.001) (Figure 2c).
In contrast there was no difference in the number of CD4+ and CD8+
T cells of CD45.1 origin in the thymus or spleen between the two sets
of chimeras (Figure 2c). The results of the fetal liver chimeras indicates
that the increase in mature T cells observed when Dll3 is absent is due
to a haemopoietic rather than a stromal defect and that Dll3 has a
non-redundant role in the regulation of ab-T-cell production in the
thymus. To confirm this finding we set up reciprocal chimeras where
bone marrow cells from CD45.1+ donor mice were transferred to
irradiated Dll3+/+ or Dll3/ mice. Twelve weeks later we analysed the
thymus and spleen and observed no difference in the number of DP
cells or mature CD4+ and CD8+ T cells in the thymus or spleen
between the different recipient mice (Supplementary Figure 1). This
result confirms that the expression of Dll3 in T cells is required for
regulating T cell development in the thymus.
Dll3 regulates the expansion of T-cell progenitors
To confirm that Dll3 acts in a cell autonomous manner in T-cell
progenitors during TCRab development, we made use of the OP9Dll1 stromal line, which can support T-cell development in vitro along
both TCRab and TCRgd cell lineages.6 Fetal liver haematopoietic stem
cells (HSCs) depleted of lineage committed cells (that is, Lin-ve)
derived from either Dll3+/+ or Dll3/ embryos (CD45.2) were
combined at different starting ratios of 5:95, 25:75 and 50:50 with
fetal liver HSCs purified from wild-type CD45.1 embryos. The HSCs
were cultured with either control OP9 cells or OP9-Dll1 cells and were
analysed by flow cytometry after 21 days. The HSCs cultured on OP9Dll1 stromal cells expanded and underwent differentiation along the
TCRab and TCRgd lineages; however, the TCRab lineage predominated for both Dll3+/+ and Dll3/ derived cell populations
(Figure 3a). We examined the proportion of CD45.2 (Dll3+/+ or
Dll3/) cells within the final cell populations at the end of the
culture period by flow cytometry. At all ratios the tested Dll3/cells
had expanded at a greater rate than the Dll3+/+cells when placed in
direct competition with CD45.1 wild-type cells (Figure 3b). Next we
examined the proportion of CD45.2 cells within the DN and DP stages
of development by flow cytometry. The Dll3+/+ cells remained at the
same proportion as the starting ratio irrespective of the stage of T-cell
development examined (Figure 3c). In contrast, Dll3/ cells always
expanded well beyond the starting ratio, for example at the 5:95 ratio,
Dll3/ cells represented on average 18% of the final DN and 12%
of the DP cells (Figure 3c). At the 25:75 ratio the Dll3/ cells
represented an average 50% of the DN and 40% of DP cells, whereas
at the 50:50 ratio the Dll3/ cells comprised about 65% of the DN
and 60% DP cells (Figure 3c).
Immunology and Cell Biology
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Figure 3 Loss of Dll3 leads to increased production of TCRab cells from
fetal liver HSCs. Fetal liver from Dll3+/+ and Dll3/ HSCs were mixed at
different ratios with E18 fetal liver HSCs from CD45.1+ embryos, these
were cultured on OP9-Dll1 stromal cells in vitro and after 3 weeks cells
were stained and analysed by FACS. (a) Representative FACS dot plots
derived from Dll3+/+ and Dll3/ cells stained with anti-TCRb and anti-TCRd
antibodies. (b) Graph shows the percentage of CD45.2 derived cells in the
total lymphocyte populations that were derived from the OP9-Dll1 stromal
cell cultures. ***P¼0.0001. (c) Graph shows the percentage of CD45.2derived DN cells (left) *P¼0.029, **P¼0.001, ***P¼0.0001 and DP cells
(right) *P¼0.019, ***Po0.001 derived from the OP9-Dll1 stromal cell
cultures. (d) FACS analysis of carboxyfluorescein diacetate succinimidyl
ester (CFSE) dilution of Dll3+/+ (black line) and Dll3/ DN cells (grey line)
grown on OP9-Dll1 cells for 3 days. Data show a representative overlay
histogram comparing CFSE expression on Thy1+ lymphocytes growing in the
cultures.

As the Dll3/ progenitors could out compete with the wild-type
cells in vitro and in vivo, we examined the proliferative capacity of the
Dll3+/+ and Dll3/ DN cells using carboxyfluorescein diacetate
succinimidyl ester labelled purified Lin-ve DN1 thymocytes. The
cells were cultured in the presence of OP9-Dll1 cells and analysed
by FACS after 3 days. The Dll3/ DN1 cells proliferated more
extensively than the Dll3+/+ cells during the same culture period
(Figure 3d). It should be noted that in this series of experiments the
bone marrow HSCs from Dll3+/+ and Dll3/ mice that were cultured
with the OP9 stromal line failed to expand in vitro over the culture
period (data not shown). Therefore the Dll3+/+ and Dll3/ HSCs
both rely on the delivery of an exogenous Notch ligand signal to
support their growth and expansion on OP9-Dll1 stromal cells in vitro
(discussed further below). Collectively these data obtained from
the irradiation chimeras and the OP9-Dll1 assays, confirmed a cell
autonomous function for Dll3 in regulating ab-T-cell development
that begins with the early T cell progenitors.
Changes in TCR signalling detected in Dll3/ DP cells
We wanted to examine if the loss of Dll3 in thymocytes leads to any
phenotypic changes during T cell development. Compared with the
Dll3+/+ cells there was no difference in the cell surface expression
of CD3, CD5 or CD69 on Dll3/ cells at any stage of T-cell
Immunology and Cell Biology

differentiation (Figure 4g and data not shown). Next we examined
whether or not we could observe changes in TCR signalling within DP
cells of the Dll3/ mice. One of the earliest events in TCR signalling is
the dephosphorylation of the inhibitory tyrosine’s on the non-receptor
tyrosine kinase p56LCK.18,19 Thymocytes from newborn Dll3+/+ and
Dll3/ mice were stained intracellularly and analysed for changes in
pLckY505, pErk, Bcl-2 and pGSK3b expression by flow cytometry.
The Dll3/ DP cells showed decreased expression of pLckY505 and
increased pErk staining compared with Dll3+/+ DP cells, but there was
no difference in Bcl-2 or pGSK3b staining (Figures 4a and b). These
changes in TCR signalling were restricted to the DP cells, as mature
CD4+ or CD8+ T cells in the thymus or spleen do not show any
difference in staining of pLckY505 or pErk between Dll3+/+ and
Dll3/ mice (Figures 4c and d and data not shown). Next we
examined whether we could observe similar changes in pLckY505
expression in the thymus of the mixed chimaeric recipients previously
described. DP cells from the thymus of the chimaeric recipients were
stained intracellularly with a pLckY505 antibody, the Dll3/ DP cells
showed a lower level of pLckY505 staining, which is indicative of
active signalling through p56Lck compared with Dll3+/+ DP cells
(Figure 4f). Comparing the mean intensity fluorescence of the
pLckY505 in DP cells of individual chimaeric mice, it was evident
that the Dll3/ DP cells had a significantly lower level of pLckY505
(Po0.05) compared with the Dll3+/+ cells in the thymus (Figure 4f).
The Dll3/ DP cells also showed evidence of increased pErk staining
(Figure 4f) but there was no difference in the expression of Bcl-2
between Dll3+/+ and Dll3/ DP cells (data not shown). Therefore the
changes in TCR signalling observed in the mutant cells in the
chimaeric recipients indicate that these changes are due to a cell
intrinsic effect caused by the lack of Dll3.
Dll3 deficiency leads to an increase in positive selection
of thymocytes
DP thymocytes will undergo either positive or negative selection
depending on the affinity of the clonotypic TCR for peptide/major
histocompatibility complex presented on the surface of epithelial cells.
T cells with a high affinity TCR are signalled to die by apoptosis
leading to clonal deletion, whereas DP cells that express a TCR with
low to intermediate affinity for peptide/major histocompatibility
complex will be positively selected and allowed to complete
their maturation and differentiate as either CD8+ or CD4+ SP cells,
respectively.
To examine the effect of the lack of Dll3 has on positive and
negative selection of antigen-specific CD4+ T cells we bred the Dll3
null allele onto to the B10.BR 3A9 TCR transgenic background, which
encodes a high affinity TCR specific for the immunodominant peptide
of hen egg lysozyme (HEL) 46–63 presented in association with I-Ak.20
An advantage of this model is that it possible to track the development
of the TCR transgenic cells throughout development in the thymus
using a clonotype-specific monoclonal antibody.21 Negative selection
of islet-specific CD4+ T cells in TCR:insHel mice is under the control
of the autoimmune regulator gene, Aire.21,22 Promiscuous expression
of the HEL protein by medullary thymic epithelial cells causes deletion
of the majority of CD4+ T cells during the single positive stage of
development. The Dll3/ TCR and TCR:insHel double transgenic
mice do not survive beyond birth on a B10.BR background requiring
us to examine irradiation chimeras using fetal liver cells from either
Dll3+/+ or Dll3/ 3A9 TCR (CD45.2) embryos or wild-type 3A9
TCR CD45.1 embryos. The 50:50 mixtures of Dll3+/+/CD45.1 or
Dll3//CD45.1 were injected into irradiated B10.BR (non-transgenic)
or B10.BR-insHel transgenic recipients that enabled us to examine the
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Figure 4 Loss of Dll3 leads to a cell autonomous change in TCR signalling in DP thymocytes. (a) Representative histograms show overlay plots of Dll3+/+
(grey shade) and Dll3/ (black fill) DP cells stained with antibodies to pLCKY505, pERK, Bcl2 and pGSK3b. (b) Graph shows the mean fluorescence
intensity (MFI) values of pLCKY505 staining for DP cells from Dll3+/+ (filled squares) and Dll3/ mice (open triangles). The difference in mean is
significant at P¼0.001. Each symbol represents data from an individual mouse. (c) Staining of mature CD4+ thymocytes with pLCKY505 and pERK.
(d) Overlay histograms comparing expression of pLCKY505. (e) Overlay histograms comparing expression of Bcl-2 expression in spleen CD4+ and CD8+
T cells. The isotype control antibody is shown as a black line. (f) Graph shows the pLCKY505 geomean expression of CD45.2+ DP cells from individual
chimaeric mice of Dll3+/+/CD45.1 (filled shapes) and Dll3//CD45.1 chimaeric animals (open shapes). Significant differences are shown, *P¼0.05 by one
way analysis of variance. The genotype of the donor cells is shown on the x axis. Each symbol represents an individual recipient. (g) Representative
histograms showing overlay plots of Dll3+/+ (gray shade) and Dll3/ (black fill) CD45.2+ DP cells stained with antibodies to CD3, CD5 and CD69,
respectively.

effect of loss of Dll3 on both positive and negative selection of 3A9T
cells, respectively. Twelve weeks after the transfer the thymus and
spleen of individual chimaeric mice were analysed by flow cytometry
and the different donor cell populations could be distinguished on the
basis of allelic expression of CD45 at the cell surface. In the Dll3+/+/
CD45.1 chimera the Dll3+/+-derived 3A9 TCR transgenic cells represented just 40% of DP cells and 25% of the mature Hel-specific CD4+
1G12+ cells (Figures 5a and b). In contrast, in the Dll3//CD45.1
chimeras the Dll3/-derived cells represented 60% of the thymocytes
at both the DP and CD4+ 1G12+ stage (Figures 5a and b). In absolute
terms the Dll3/ 3A9 progenitor cells gave rise to threefold more
mature CD4+ 1G12+ T cells than the comparable Dll3+/+ 3A9 TCR
population (Po0.001), whereas there were equivalent numbers of DP
cells in both sets of chimeras (Figure 5c). These differences were also

maintained in the spleen (Supplementary Figure 2). In contrast the
CD45.1-derived progenitor cells gave rise to equivalent numbers of DP
cells and mature CD4+ 1G12+ T cells in the chimeras (Figure 5c).
These results confirm that the loss of Dll3 leads to increased positive
selection of antigen-specific T cells confirming the cell autonomous
role for Dll3 in T-cell development. Flow cytometric analysis of
the thymus and spleen of insHel recipients revealed that there
was no defect in negative selection in the absence of Dll3 as both
sets of chimeras gave rise to equivalent numbers of DP and CD4+
1G12+ T cells (Supplementary Figure 2). Furthermore none of
the insHel recipients developed type 1 diabetes confirming that
clonal deletion of the islet-reactive CD4+ T cells was sufficient to
maintain tolerance to the islet-specific Hel antigen in the presence and
absence of Dll3.
Immunology and Cell Biology
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Figure 5 Enhanced positive selection of Hel-specific T cells in vivo in the
absence of Dll3. (a) Representative FACS dot plots showing CD4 versus CD8
expression of total thymocytes from Dll3+/+ TCR/CD45.1+TCR+4B10.Br
chimaeras or Dll3/ TCR+/CD45.1+TCR+4B10.Br chimaeras (top panel).
Lower panel shows CD4 versus 1G12 staining on the CD4-gated thymocyte
population. (b) Representative histograms showing the proportion of CD45.1+
and CD45.1– cells in the DP or CD4+ 1G12+ gates of representative
chimaeras. (c) Graphs show the total cell numbers of DP and CD4+ 1G12+
cells in the thymus of individual chimaeric mice. Cells from the Dll3+/+/
CD45.1 chimeras (filled squares), and Dll3//CD45.1 chimaeras (open
triangles) are shown.

Dll3/ progenitors rely on a Notch signal for T-cell differentiation
We wanted to determine if the Dll3/ thymic progenitors were still
dependent on ligand-induced Notch signalling during T-cell differentiation. FACS-purified Dll3+/+ and Dll3/ DN1 thymocytes were
Immunology and Cell Biology

cultured on OP9-Dll1 cells in the presence or absence of the
g-secretase inhibitor L-685,458 that inhibits the activity of both
presenilin 1 and 2.6,10 L-685,458 potently inhibited cell proliferation
in these assays consistent with previous observations.10,23 The Dll3+/+
DN cells display a dose-dependent block in T-cell development in the
presence of L-685,458 with a reduction in frequency of DP cells
generated and there is a corresponding increase in the proportion of
B220+ cells (490%) in these cultures consistent with a block of
Notch1 signalling in DN precursors (Supplementary Figure 3). The
Dll3/ DN cells were also sensitive to the inhibitory effects of
L-685,458 such that DP cell differentiation was reduced but a
significant fraction of T-lineage-committed cells remained (B30%)
in these cultures even at the highest concentration of inhibitor (1 mM)
whereas Dll3+/+ cells contained o5% T cells at the same concentration
(Supplementary Figure 3). Treatment of Dll3/ DN cells with the
inhibitor did increase the proportion of B cells in these cultures but
they were less than those produced with Dll3+/+ cells (Supplementary
Figure 3). The differentiation of Dll3+/+ or Dll3/ DN cells was not
affected by the presence of a g-secretase inhibitor that does not impair
Notch cleavage (data not shown). We conclude that the Dll3/
thymocytes are still reliant on ligand-induced Notch1 signalling to
drive lineage commitment and subsequent T-cell differentiation.
Next we wanted to determine if the loss of Dll3 lead to an increase
in Notch signalling within Dll3 deficient thymocytes. To test this
hypothesis we examined the expression of a range of Notch signalling
target genes using RNA from FACS-purified DN and DP cells isolated
from thymus of age and sex matched Dll3+/+ and Dll3/ mice.
The data presented in Figure 6b shows the relative expression of the
different target genes in Dll3/ DN or DP cells compared with the
equivalent Dll3+/+ cell population, which was given an arbitrary value
of 1. Hes1 and Hes5, are direct target genes of Notch1 signalling in
thymocytes.24 There was a fourfold increase in Hes5 in the Dll3/
DP cells but no change could be detected in Hes1 expression.
We conclude that at the level of Notch target gene regulation the
loss of Dll3 is unlikely to lead to global dysregulation of Notch
signalling in DN or DP cells.
To test whether Dll3 can activate Notch signalling in trans, we
utilised a co-culture assay in which cell lines expressing Dll1 (3T3-D1),
Dll3 (3T3-D3) or Jagged1 (3T3-J1) ligands were co-cultured with C2C12
cells that stably expressed the Notch1 receptor (C2C12-N1).25,26 The
Dll1 and Jagged1 expressing cells could activate Notch1 signalling in
trans and strongly induce transcription of the Notch responsive
reporter gene. In contrast, presentation of Dll3-expressing cells in
trans was unable to activate transcription of the Notch reporter gene
(Figure 7a).
We further examined the cell autonomous function of Dll3 on
Notch signalling by examining if the different Notch ligands were able
to modulate Notch signalling when expressed in the same cell as the
Notch1 receptor (in cis). Dll1 and Jag1 potently inhibited transactivation of Notch signalling induced by co-culturing with 3T3-D1
or 3T3-J1 cells (Figure 7b). Expression of Dll3 in the Notch-expressing
cells also consistently inhibited signalling regardless of whether 3T3D1 or 3T3-J1 cells were used to induce Notch signalling (Figure 7b).
Interestingly, Dll3 did not inhibit signalling to the same extent as Dll1
or Jagged1 (Figure 7c). Residual Notch signalling was B2–3-fold
higher in cells expressing Dll3 in cis compared with those expressing
Dll1 in cis. This property of Dll3 was also observed when C2C12-N1
cells were replaced with Notch1-transfected NIH3T3 cells in the
co-culture assay (Figure 7d). These results confirm the previous
findings showing that Dll3 cannot activate Notch signalling when
expressed in trans with the receptor8 but they also extend our
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Figure 6 T-cell production by
precursors is dependent on Notch
cleavage by g-secretases. (a) Lineage negative DN cells isolated from the
thymus of either Dll3+/+ or Dll3/ mice were cultured on OP9-Dll1 cells in
the presence or absence of the g-secretase inhibitor L-685,458
(Calbiochem, gsi-X) at the indicated concentrations. FACS analysis of CD4
versus CD8 expression was made 8 days after commencement of the
culture. Graph shows the frequency of DP cells at the end of the culture
period Dll3+/+ (filled squares), Dll3/ (open triangles). There was a
statistically significant difference in the frequency of DP cells between
Dll3+/+ and Dll3/ cells at P¼0.018 (0.1 mg ml1), P¼0.0006 (1 mg ml1)
and P¼0.0289 (10 mg ml1). (b) Expression of Notch target genes Hes-1,
Hes-5 and Dtx1 in Dll3+/+ (black bars) and Dll3/ (grey bars) DN and DP
thymocytes using real time PCR. **Statistically significant difference in
Hes5 expression is shown P¼0.005. Data show the average gene
expression (s.d. obtained from analysis of FACS-purified DN and DP cells
generated from three independent samples from Dll3/ and Dll3+/+ mice.
ND, not detected.

understanding of Dll3, in that unlike Dll1, Dll3 does not completely
cis-inhibit Notch signalling.
DISCUSSION
Until now the investigation of the role of Notch ligands in the thymus
have focussed on their role in thymic stromal cells, which express Dll1,
Dll4 and Jagged 1 ligands.4–6,11 Here we have identified a novel cell
autonomous role for Dll3 in thymocytes during the differentiation of
ab-T cells. The Dll3 ligand cannot activate Notch signalling when
expressed in trans, but can inhibit Notch signalling although not as
efficiently as other DSL ligands when expressed in cis. A deficiency in
Dll3 leads to increased positive selection of SP thymocytes whereas
negative selection of autoreactive T cells remains intact. In DP cells the
loss of Dll3 leads to increased expression of the Notch target gene Hes5
as well as TCR signalling. Therefore the Dll3 ligand appears to have
evolved a novel regulatory role in the modulation of Notch signalling
and this property is utilised by the immune system during T-cell
differentiation.

Notch signalling is crucial to normal T-cell development and
dysregulation of this signalling pathway through inherited or spontaneously acquired somatic mutations can lead to T-cell leukaemia.27
Most focus on the role of Notch ligands in T-cell development has
been on stromal cells. Cell autonomous inhibition and intracellular
association with Notch is a property of the DSL ligands when they are
overexpressed in cis.28–31 Dll3, unlike Dll1 and Jagged1, is unable to
activate Notch when expressed in trans. Through evolution the Dll3
protein has undergone several changes with respect to the other Deltalike ligands. The DSL domain that is crucial in ligand binding to
Notch receptors32 and the epidermal growth factor-like repeats 1 and
2 of Dll3 are highly divergent compared with the other related Notch
ligands.14,33 Also the Dll3 protein lacks key lysine residues in its
C-terminal domain, which are important for ubiquitination and
association with PDZ domain proteins.34–37 Our findings are similar
to those of Ladi et al.8 who also found that Dll3 was unable to activate
Notch in trans but can function in cis-inhibition of Notch signalling.
In support of an inhibitory role for Dll3 in thymocyte development we
found that the loss of Dll3 leads to an increase in Hes5 expression in
DP cells, a direct target gene of Notch signalling.24 Dll3 deficient
thymocytes were also less susceptible to the inhibitory effects of a
g secretase inhibitor that blocks ligand-dependent Notch cleavage
and this lead to a significant increase in the frequency of DP cells in
OP9-Dll1 stromal cultures with Dll3 deficient thymocytes. This result
would be expected if Dll3 deficient thymocytes had a constitutively
higher basal level of Notch signalling compared with wild-type cells
that would promote the differentiation of DP cells.
The changes in Notch signalling in Dll3/ DP cells were not
associated with any significant change to cell surface expression of
differentiation markers including CD3, CD5 or CD69 but the mutant
DP cells did show an increase in TCR signalling with enhanced
dephosphorylation of the tyrosine kinase p56lck that associates with
the TCR and increased phosphorylated-Erk staining. The changes in
TCR signalling were also observed in DP cells in both intact Dll3/
mice as well as in Dll3/-derived DP cells in mixed irradiation
chimeras. There is evidence that Notch1 and Numb can associate with
the TCR at the surface of T cells,38 which raises speculation that
perhaps Dll3 may act in DP cells to sequester Notch away from the
TCR and in turn this could help to modulate TCR signalling and in
turn limit the potential for positive selection. In the absence of Dll3,
Notch signalling becomes more active and this could synergize with
TCR signals to promote T-cell differentiation. The increase in TCR
signalling in DP cells resulted in enhanced positive selection of SP
thymocytes that was most evident in mixed irradiation chimeras
showing that Dll3 acts cell autonomously in thymocytes. Importantly,
the loss of Dll3 did not affect the fidelity of negative selection of
autoreactive thymocytes. The ubiquitin E3 ligase Itch has recently been
shown to regulate JunB in Th cells and is important in the regulation
of Th2 cell differentiation.39 Itch can ubiquitinate Notch receptors and
target it for proteolytic degradation by the proteosome. Notch signalling has been shown to be important in Th2 cell differentiation that is
induced by Notch ligands expressed by professional APCs.3,40–42 Itchy
mice develop a late onset of an autoimmune like disease characterized
by lymphoproliferation in the spleen, lymph nodes and thymic
medulla.43,44 Also when combined with an activated Notch1 allele
the Itch mutation could synergize with Notch to cause autoimmune
disease in mice.45 Although the loss of Dll3 could lead to an increase in
positive selection of SP cells, it did not affect clonal deletion of
autoreactive T cells. The 3A9 TCR:insHel model is a validated model
to study organ-specific autoimmune diseases such as type 1 diabetes
and heterozygous mutations in autoimmune susceptibility genes such
Immunology and Cell Biology
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Figure 7 Dll3 mediates cis-inhibition of Notch. (a) The CBF1/Su(H)/Lag1 responsive promoter TP-1 coupled to a luciferase reporter (TP1-luc) was introduced
into C2C12 cells stably expressing a full-length Notch1 receptor (C2C12-N1), the C2C12-N1 cells were co-cultured with NIH3T3 cells stably expressing
either Dll1 (3T3-D1), Jagged1 (3T3-J1) or Dll3 (3T3-D3). Error bars represent the s.d. of the mean. A representative experiment is shown. (b) Cis-inhibition
of Notch signalling by Dll3 in C2C12-N1 cells. Notch reporter activity in C2C12-N1 cells transfected with either Dll1, Jagged1 or Dll3 ligands and the
TP1-luc reporter following co-culture with either control (3T3-C; white bars), 3T3 cells expressing Dll1 (3T3-D1; grey bars) or Jagged1 (3T3-J1; black bars).
Data are expressed relative to Cat control co-cultured with 3T3-C cells. Representative experiments are shown. Error bars represent the s.d. of the quotient.
(c) Cis-inhibition of Notch signalling by Dll3 in C2C12-N1 cells. Notch reporter activity in C2C12-N1 cells transfected with either Dll1 or Dll3 ligands and
the TP1-luc reporter following co-culture with 3T3 cells expressing Dll1 (3T3-D1; white bars) or Jagged1 (3T3-J1; black bars). Data from four independent
experiments are represented as fold induction (ligand over control cells) relative to control. One-way analysis of variance was performed and significance
determined using the Tukey’s multiple comparison test. ***Po0.001. Error bars represent the s.d. from the mean. Notch signalling was induced at least
fourfold in all experiments. (d) Cis-inhibition of Notch signalling by Dll3 in NIH3T3 cells. Notch reporter activity in NIH3T3 cells transfected with Notch1,
TP1-luc reporter and either Dll1, Jagged1 or Dll3-HA ligands and then co-cultured with the same 3T3-C (white bars), 3T3-D1 (grey bars) or 3T3-J1 cells
(black bars) as described above. Data are expressed relative to Cat control co-cultured with 3T3-C cells. A representative experiment is shown. Error bars
represent the s.d. of the quotient.

as Aire, Il2 and Roquin can all lead to a breakdown in self tolerance
and rapid onset of type 1 diabetes.21,46,47 However the Dll3/
mutation in autoreactive thymocytes did not affect clonal deletion
and did not lead to the aberrant survival of autoreactive T cells in the
periphery. In addition, we have not observed any significant change in
Th1, Th2 or Th17 cell differentiation in vivo.
These studies are the first to show that Dll3 has an important and
non-redundant role in the immune system to regulate T-cell development. Further studies are required to understand exactly how Dll3
functions to regulate Notch signalling in T cells but this may be of
wider importance given the important role that Dll3 has in the
development of the nervous system and mutations in Dll3 have
been shown to be responsible for human disease.14,17,48
METHODS
Mice
Dll3/ mice were bred on a (C57BL/6129) F1 background at the Victor
Chang Cardiac Research Institute, Darlinghurst, Sydney, Australia. The irradiation chimeras used E14 fetal liver cells from Dll3/ or Dll3+/+ mice on a
C57BL/6J background (backcrossed 410 generations) that were syngeneic with
the C57BL/6 CD45.1 congenic mice. CD45.1 congenic mice were purchased
from the Animal Resources Centre, Murdoch, Western Australia, Australia. The
3A9 TCR transgenic mice on a B10.Br background were bred with Dll3/ mice
and backcrossed for six generations before use in the fetal liver chimera assay.
Immunology and Cell Biology

B10.BR, B10.Br insHel transgenic mice and B10.BR 3A9 TCR CD45.1 congenic
mice were all bred at the Australian Phenomics Facility at the Australian
National University (ANU). All experiments were performed in accordance
with animal ethics regulations.

Cell lines
The OP9-GFP and OP9-Dll1 stromal cells were obtained from Dr J-C ZunigaPflucker (University of Toronto, Canada).6 The cells were maintained in
a-minimum essential medium supplemented with penicillin/streptomycin
and 20% fetal calf serum. C2C12, C2C12-N125 and NIH3T3 were obtained
from the ATCC and maintained in Dulbecco’s modified Eagle’s medium
medium containing 10% fetal calf serum.

Generation of Dll3-specific antibody
Guinea pig antisera were raised against the peptide SADWNHPEDGDSRS
mapping to residues 558–571 near the C-terminus of mouse Dll3 and affinitypurified according to the manufacturer’s instructions (PSL GmbH, Heidelberg,
Germany). Western blotting and was performed as previously described.25

Notch signalling reporter assays
Mouse complementary DNAs of Dll1, Jagged1and Dll3 were cloned, using the
Gateway system (Invitrogen, Victoria, Australia) into the expression vector
pCMX. Dll3 was Gateway-cloned into pCAG-IRES-HA-Puro to create pCAGDll3HA-iPuro. NIH3T3 cells overexpressing mDll3 were generated by stably
transfecting pCAG-Dll3HA-iPuro followed by selection in 1.5 mg ml1 puromycin for 10 days. Isolated cell clones were picked, expanded and analysed for
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expression of Dll3 by immunofluorescence and western blotting with an antihaemagglutinin antibody.
Transfections were performed using LipofectAMINE and Plus reagent
(Invitrogen) according to the manufacturer’s instructions. Luciferase assay
transfections in 12-well trays contained 14 ng of CMV-renilla plasmid, 350 ng
of p6xTP1-Luc and 350 ng of each expression plasmid or pCAT-CMX control
plasmid. Co-cultures were established by addition of 2105 NIH3T3 cells stably
transfected with vector (3T3-C), NIH3T3 cells expressing mDll1 (3T3-D1) or
mJagged1 (3T3-J1).49 Co-cultures were harvested 24 h after transfection in
200 ml of passive lysis buffer (Promega, Sydney, Australia). Transient transfection of NIH3T3 cells and co-culture with 3T3-C, 3T3-D1 and 3T3-J1 cells was
performed as in Ladi E et al.8 Firefly and renilla luciferase activities were assayed
using the dual-luciferase reporter system (Promega) and measured on a
FLUOstar Optima Luminometer (BMG LabTech, Victoria, Australia). Firefly
luciferase counts were normalised against renilla luciferase counts to account
for differences in transfection efficiency.

Flow cytometry
Single cell suspensions from thymus, spleen, lymph node and bone marrow
were prepared from mice at 5 and 10 weeks of age and stained for three or
four colour FACS analysis using standard procedures. Results were analysed
with Cell Quest software (BD Biosciences, San Jose, CA, USA) on a FACS
Calibur flow cytometer. The antibodies used in these experiments included:
anti-B220-APC or Prcp (clone RA3-6B2, Pharmingen, Sydney, Australia), antiCD4-APC or PE (clone GK1.5), anti-CD8-Prcp or FITC (clone 53-5.8;
Pharmingen), anti-Thy1-PE, anti–TCRb-FITC (clone H57-597; Pharmingen),
anti-TCRgd (clone GL3), anti-CD3-FITC or PE (clone 2C11), anti-CD44 APC,
anti-CD69-PE, anti-CD25-PE or APC (clone PC-61) and anti-CD5-biotin.
For intracellular staining, cells were incubated with primary antibodies,
washed and fixed and permeabilised with cytofix/cytoperm buffer (BD Pharmingen,
Sydney, Australia) for 20 min at 4 1C, the cells were washed with perm/wash
buffer (BD Pharmingen) and incubated with the anti-Dll3 antibody or a guinea
pig isotype control overnight at 4 1C. Cells were washed and stained with antiguinea pig-PE+FC block antibody for 3 h at 4 1C and the cells were washed and
analysed by FACS. To examine intracellular signalling in thymocytes, cells were
stained with primary antibodies to cell surface markers and then fixed and
permeabilised. Antibodies, pLckY505-FITC, pErk-FITC, Bcl-2-FITC or isotype
controls-FITC (all from BD Pharmingen) were added for 3 h at 4 1C and the
cells were washed and analysed by FACS. Anti-phospho-Gsk-3b was purchased
from Cell Signalling Technology (Danvers, MA, USA).

or Dll3/ mice. The recipients were analysed 10–12 weeks after the transfer.
Fetal liver cells from Dll3+/+ and Dll3/ animals (on the 3A9 TCR transgenic
B10.BR background) were mixed with fetal liver cells from 3A9 TCR-CD45.1
congenic mice and these were injected intravenously at a 50:50 ratio to
irradiated B10.Br or B10.Br-insHel transgenic recipient mice.

In vitro T-cell differentiation assays
Lineage negative HSCs were prepared by magnetic antibody cell separation
(MACs) of fetal liver or bone marrow cell suspensions made from either
Dll3+/+ or Dll3/ animals. Briefly, bone marrow cells were cultured with a
cocktail of biotinylated antibodies including anti-CD4, anti-CD8, anti-TCRb,
anti-TCRgd and anti-B220 (all from Pharmingen). Cells were washed and
incubated with streptavidin magnetic microbeads (Miltenyi Biotech, Sydney,
Australia) and the cells were passed over a magnetic field through an LS
column. Non-bound cells were collected, washed and set up in culture at 5103
cells per well in a 24-well plate. Cells were cultured in medium containing
a-minimum essential medium+20% fetal calf serum+penicillin-streptomycin
and glutamine, 5 ng ml1 interleukin-7 and 5 ng ml1 Flt3L on either control
OP9-GFP or OP9-Dll1 cells at 37 C. After 21 days, cells were collected
and analysed by FACS. To study the effect of the L-685,458 (gsi-X, Calbiochem)
or JLK6 (gsi-XI, Calbiochem, San Diego, CA, USA) treatment on T-cell
development, bone marrow-derived cells were cultured on OP9-Dll1 cells in
the presence or absence of various concentrations of the two inhibitors, and
T-cell development was assessed by flow cytometry.
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Real time PCR
Complementary DNA was generated from DNase1-treated (DNA free, Ambion,
Melbourne, Australia) RNA (isolated using Trizol reagent, Invitrogen, Life
Technologies, Carlsbad, CA USA). Primers and fluorogenic probes for Hes1
and Hes5 were purchased from Applied Biosystems (Melbourne, Australia).
Quantitative PCR was performed for 40 cycles using an icycler iQ (Bio-Rad,
Hercules, CA, USA). The cycle threshold values for experimental samples were
converted to relative complementary DNA levels based on the standard curve
for each primer set. Expression levels for individual samples were normalised to
the house keeping gene ubiquitin conjugating enzyme (Ubc) calculated
similarly from the standard curve for those primers. These normalized
values are presented in units and represent the change in cycle threshold values
subtracted from Dll3/ versus Dll3+/+ cells. These data were collected from
FACS-purified DN and DP samples from three individual mice.

Irradiation chimeras
Fetal liver cells from Dll3+/+ and Dll3/ animals (on the C57BL/6 background)
were collected from E14 post coital embryos, cell suspensions were injected at
different cell ratios with fetal liver cells from wild-type CD45.1 embryos and
were injected into sublethally irradiated CD45.1 mice receiving two doses
of 5 Gy g-irradiation (Cs source, CSIRO, Canberra, Australia) given 3 h
apart. Animals were given water-containing antibiotics for the first 3 weeks
and mice were analysed between 8–12 weeks post injection. Reciprocal
chimeras were also set up whereby wild-type bone marrow cells from
CD45.1+ donor animals, which were injected into either irradiated Dll3+/+
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